Results 1 to 10 of about 13,617 (225)

Biologic Switching in Patients with Severe Asthma: Effects on Exacerbations, Corticosteroid Use and Lung Function. [PDF]

J Clin Med
Dindar Çelik F, Aksu K.
europepmc   +1 more source

Biologic switching in allergic bronchopulmonary aspergillosis: a scoping review of published clinical experience. [PDF]

J Thorac Dis
Hu Q, Pan X, Chen R, Li G, Li Y, Zheng Y, Zhong Z, Zhang X, Chen Y, Ye J, Duan J, Li J.   +11 more
europepmc   +1 more source

The Clinical and Economic Impact of Biologic Agents in Asthma Management: a Systematic Review. [PDF]

Lung
Procacci C, Gualano MR, Maurmo L, Valentini I, Mao S, Ricciardi W.   +5 more
europepmc   +1 more source

Omalizumab Therapy Results in Defined Behavioural Changes and Improvements in Quality of Life in Solar Urticaria. [PDF]

Photodermatol Photoimmunol Photomed
Parkin D, Marjanovic EJ, Farrar MD, Rhodes LE, Rutter KJ.   +4 more
europepmc   +1 more source

Real-life lessons on omalizumab and food allergy: The potential for unexplored outcomes. [PDF]

World Allergy Organ J
Lo Scalzo L, Galletta F, Cafarotti A, Nurmatov U, Klimek L, Fiocchi A, Arasi S.   +6 more
europepmc   +1 more source

Omalizumab demonstrates efficacy and safety in Chinese children under 12 with chronic urticaria: a case series. [PDF]

Front Pediatr
Zhao H, Luo L, Jia WM.
europepmc   +1 more source

Efficacy predictions for omalizumab treatment based on basophil CD203c expression in patients with allergic rhinitis by basophil activation test -- a real-life, pilot study. [PDF]

World Allergy Organ J
Zhao Z, Chen H, Liu T, Hong J, Deng Y, Hua Q.   +5 more
europepmc   +1 more source

From anaphylaxis to eosinophilic esophagitis during omalizumab treatment in a boy with severe asthma and food allergy: a case report. [PDF]

Front Immunol
Jedynak-Wąsowicz U, Klim L, Cichocka-Jarosz E.   +2 more
europepmc   +1 more source

Age-specific efficacy of biologics in severe asthma: a pediatric perspective. [PDF]

Front Allergy
Andrenacci B, Calciano F, Madini B, Rocchi A, Ghiglioni DG, Maffeis L, Patria MF, Licari A, Marseglia GL.   +8 more
europepmc   +1 more source

Real-world efficacy and safety of omalizumab in chronic spontaneous urticaria: Insights from the Middle East. [PDF]

J Allergy Clin Immunol Glob
Elkhalifa S, Mahmoud E, Salvo F, AlHameli H, Cerecedo I, Shafiq I, Abuzakouk M.   +6 more
europepmc   +1 more source